Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
Virologica Sinica|September 23, 2023
Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitorMeiyue Dong, Yanyan Wang, Ping Li, et al.Cellular Microbiology|September 25, 2009
Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibitionOsvaldo Martinez, Joshua Johnson, Balaji Manicassamy, et al.Viruses|December 6, 2018
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola VirusQinghua Cui, Han Cheng, Rui Xiong, et al.Journal of Ethnopharmacology|January 7, 2024
Integrated serum pharmacochemistry and investigation of the anti-influenza A virus pneumonia effect of Qingjin Huatan decoctionMiaomiao Liu, Zhongyuan Li, Qinghua Cui, et al.Cell Reports|April 27, 2022
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entryEnya Qing, Pengfei Li, Laura Cooper, et al.Journal of Molecular Biology|October 27, 2009
Identification of a new region of SARS-CoV S protein critical for viral entryYing Guo, Jennifer Tisoncik, Susanna McReynolds, et al.Viruses|June 15, 2018
A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia LuciferasePing Li, Qinghua Cui, Lin Wang, et al.Journal of Ethnopharmacology|February 12, 2026
Sangbaipi Decoction mitigates influenza pneumonia in mice by inhibiting ZBP1-mediated PANoptosisChengcheng Zhang, Guofeng Yu, Miaomiao Liu, et al.Plos Pathogens|August 4, 2022
Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategyXiujuan Zhao, Xiaojing Lin, Ping Li, et al.Current Medicinal Chemistry|October 17, 2017
Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus DiseaseAdam Schafer, Han Cheng, Charles Lee, et al.Pageof 17